Form 8-K - Current report:
SEC Accession No. 0001493152-23-027356
Filing Date
2023-08-09
Accepted
2023-08-09 16:15:36
Documents
12
Period of Report
2023-08-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38953
  Complete submission text file 0001493152-23-027356.txt   213113

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ards-20230804.xsd EX-101.SCH 3027
3 XBRL LABEL FILE ards-20230804_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ards-20230804_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3398
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38630 | Film No.: 231155357
SIC: 2834 Pharmaceutical Preparations